Friday, 19 August 2016
NICE set to remove two drugs from the Cancer Drugs Fund
NICE set to remove two drugs from the Cancer Drugs Fund Everolimus for breast cancer and ibrutinib for mantle cell lymphoma are not cost-effective, NICE says. OnMedica
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment